Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for macrophage 1 antigen
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Most Relevant Literature
- Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic an…
- Aspergillus fumigatus Induces the Release of IL-8 and MCP-1 by Activating Nuclear Transcription Thro…
- A (1→6)-Branched (1→4)-β-d-Glucan from Grifola frondosa Inhibits Lipopolysaccharide-Induced Cytokine…
- Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse …
- Separation of chitooligosaccharides and the potent effects on gene expression of cell surface recept…
Most Relevant Clinical Trials
- Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome
- RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)
- Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
- Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-sti…
- Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma
